Modifier JW With Drug Codes

June 27th, 2017 - Find-A-Code
Categories:   Coding   Modifiers   Drugs|Pharmaceuticals|FDA  
0 Votes - Sign in to vote or comment.

Modifier JW

In the past, some Medicare Administrative Contractors have required providers to report wasted drugs with modifier JW (Drug amount discarded/not administered to any patient). Use of the modifier was at the contractor’s discretion, and some contractors told providers not to report it. But effective January 1, 2017, all providers (hospitals, freestanding centers and physician offices) will be required to use modifier JW, and they will continue to be required to document the amount of discarded drug in the individual patient’s medical record. Medicare’s discarded drug policy is located in Chapter 17 of the Medicare Claims Processing Manual. Briefly, it states that when a provider administers part of a single-use vial or other single-use package to a Medicare patient, and the rest of the container must be discarded, Medicare will pay both for the amount that was administered and the amount that was discarded. Note that this policy applies only to single-use containers or single-use vials. If part of a multi-use container is discarded, the provider may bill only for the amount that was actually administered to the patient.

The provider must report the drug on the claim as two separate charges: one claim line for the amount administered (with no modifier), and one claim line for the discarded drug amount, with modifier JW. For example, code J9035 represents Avastin (bevacizumab): 1 unit per 10 mg. If a patient is given 980 mg from two 400 mg and two 100 mg single use vials (total 1000 mg), and the remainder of the last vial is discarded (20 mg), the provider should report the following:

J9035 x 98 units (administered 980 mg)

J9035-JW x 2 units (wasted 20 mg)

Remember to price each line appropriately as well; the charge for the drug administered + the charge for the drug amount wasted should equal the total dollar amount of drug billed. Providers will be paid for both claim lines; CMS simply wants to track the amount Medicare pays for wasted drugs. CMS states that modifier JW should not be used “if the billing unit is equal to or greater than the total actual dose and the amount discarded.” For example, 2 mcg of sincalide is administered to a patient from a 5 mcg single use vial, and the remainder is discarded. Sincalide is reported with code J2805 (Injection, sincalide, 5 micrograms). Since 1 unit of the code is equal to the total amount administered plus the amount discarded, the provider will report 1 unit of code J2805 and modifier JW will not be applied.

###

Questions, comments?

If you have questions or comments about this article please contact us.  Comments that provide additional related information may be added here by our Editors.


Latest articles:  (any category)

​​Polysomnography Services Under OIG Scrutiny
September 2nd, 2021 - Raquel Shumway
The OIG conducted a study dated June 2019 wherein they indicated that there were approximately $269 million in overpayments for polysomnography services for the period of 2014 through 2015. According to the OIG “These errors occurred because the CMS oversight of polysomnography services was insufficient to ensure that providers complied with Medicare requirements and to prevent payment of claims that didn’t meet those requirements.” So what are those requirements?
Medicare Advantage - The Fastest Growing Government-Funded Program Undergoing Multiple Fraud Investigations
August 16th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
Medicare Advantage is the fastest growing form of government-funded healthcare and the rate of fraud within this segment has come under increased scrutiny. Funding is determined by the health status of each beneficiary; therefore, accurate coding based on detailed documentation makes the medical record vital to the process because some ...
Billing Dental Implants under Medical Coverage
August 12th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
Implants can be costly to the patient and the provider, and it is crucial to understand how to bill a patient’s medical insurance to ensure there is adequate coverage for the best treatment. Implants are commonly billed in a dental office under a patient’s medical benefits.    Implants could be considered ...
New Codes for COVID Booster Vaccine & Monoclonal Antibody Products
August 10th, 2021 - Wyn Staheli, Director of Research
New codes have been announced for the COVID-19 booster vaccine, Novavax vaccine, and monoclonal antibody treatment.
Medicare's ABN Booklet Revised
July 29th, 2021 - Wyn Staheli, Director of Research
The “Medicare Advance Written Notices of Non-coverage” booklet, published by CMS’s Medicare Learning Network, was updated. This article discusses the changes to this booklet regarding the use of the ABN.
Chronic Pain Coding Today & in the Future
July 19th, 2021 - Wyn Staheli, Director of Research
Properly documenting and coding chronic pain can be challenging. As is commonly the case with many conditions, over the years, there has been a shift in the identification of different types of pain, including chronic pain. Understanding where we are now and where we are going will help your organization prepare for the future by changing documentation patterns now.
How Does Global and Professional Direct Contracting (GPDC) Affect Risk Adjustment?
July 15th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
CMS recently announced the 53 Direct Contracting Entities (DCEs) that will be participating in the April 1, 2021 through December 31, 2021 Global and Professional Direct Contracting (GPDC) Model. Among those participating is Clover Health Partners, who runs an in-home primary care program that has the potential to help Medicare ...



Home About Contact Terms Privacy

innoviHealth® - 62 E 300 North, Spanish Fork, UT 84660 - Phone 801-770-4203 (9-5 Mountain)

Copyright © 2000-2021 innoviHealth Systems®, Inc. - CPT® copyright American Medical Association